Dynavax Technologies (DVAX) halted ahead of FDA adcom
- Wall Street rises in volatile session ahead of jobs data
- Market Wrap: ISM Services Slip in August; Markets Mixed Ahead of Nonfarm Jobs Data; Brady Tops Goodell in Court
- After Hours Stocks Movers 09/03: (BLOX) Higher; (VNCE) (UTIW) (PAY) (more...)
- Twitter (TWTR) Seen as 'Compelling' Ahead of Board Meeting, CEO Search Results
- Lannett (LCI) to Acquire Kremers Urban Pharmaceuticals in $1.23B + Contingency Payments Deal
Dynavax Technologies Corporation (NASDAQ: DVAX) halted ahead of FDA adcom
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) Ticks Higher
- PIMCO's Total Return Fund assets under management drop below $100 billion - Reuters
- Kyle Bass petitions to cancel four of five Acorda (ACOR) patents on Ampyra - Bloomberg
Create E-mail Alert Related CategoriesFDA, Trader Talk, Trading Halts
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!